US20080078411A1 - Tongue implant for sleep apnea - Google Patents
Tongue implant for sleep apnea Download PDFInfo
- Publication number
- US20080078411A1 US20080078411A1 US11/542,455 US54245506A US2008078411A1 US 20080078411 A1 US20080078411 A1 US 20080078411A1 US 54245506 A US54245506 A US 54245506A US 2008078411 A1 US2008078411 A1 US 2008078411A1
- Authority
- US
- United States
- Prior art keywords
- tongue
- implant
- base
- region
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/56—Devices for preventing snoring
- A61F5/566—Intra-oral devices
Definitions
- This invention pertains to a method for treating a condition of an upper airway of a patient. More particularly, this invention is directed to a method for treating obstructive sleep apnea by stiffening a tongue of a patient.
- OSA obstructive sleep apnea
- snoring have received a great deal of attention. These conditions have recognized sociological and health implications for both the patient and the patient's bed partner.
- tongue suspension This procedure, referred to as tongue suspension, is also described in Miller et al., “Role of the tongue base suspension suture with The Repose System bone screw in the multilevel surgical management of obstructive sleep apnea”, Otolaryngol. Head Neck Surg ., Vol. 126, pp. 392-398 (2002).
- Another technique includes debulking tissue by applying radio frequency ablation to either the tongue base or of the soft palate to debulk the tissue of the tongue or palate, respectively.
- This technique is illustrated in U.S. Pat. No. 5,843,021 to Edwards et al. dated Dec. 1, 1998.
- RF tongue base reduction procedures are described in Powell et al., “Radiofrequency tongue base reduction in sleep-disordered breathing: A pilot study”, Otolaryngol. Head Neck Surg ., Vol. 120, pp. 656-664. (1999) and Powell et al., “Radiofrequency Volumetric Reduction of the Tongue—A Porcine Pilot Study for the Treatment of Obstructive Sleep Apnea Syndrome”, Chest , Vol. 111, pp. 1348-1355 (1997).
- a surgical hyoid expansion to treat OSA is disclosed in U.S. Pat. No. 6,161,541 to Woodson dated Dec. 19, 2000.
- Other tongue treatments for OSA include stimulation of the hypoglossal nerve. This procedure is described in Eisle et al., “Direct Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea”, Arch. Otolaryngol. Head Neck Surg ., Vol. 123, pp. 57-61 (1997).
- European Patent EP 1,039,859 B1 granted Dec. 3, 2003 describes a brace placed in the tongue.
- German Patent No. 19 920 114 describes struts in pharyngeal wall.
- U.S. patent applications Publication Nos. US 2005/0126563 A1 published Jun. 16, 2005 and US 2005/0199248 A1 published Sep. 15, 2005 describe stents in an airway.
- U.S. patent applications Publication Nos. US 2004/0139975 published Jul. 22, 2004 and US 2004/0149290 published Aug. 5, 2005 both assigned to Apneon Inc.
- obstructive sleep apnea of a patient is treated by identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient.
- the method includes identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue and stiffening a tissue of the tongue throughout the identified region.
- FIG. 1 is a side sectional schematic view of an upper airway of a patient and illustrating various anatomical features
- FIG. 2 is the view of FIG. 1 showing an implant of the present invention placed within the tongue according to a treatment method of the present invention
- FIG. 3 is a side elevation view of the implant of FIG. 1 ;
- FIG. 4 is a perspective view of the implant of FIG. 3 ;
- FIG. 5 is the view of FIG. 1 showing an incision formation tool placed within the tongue;
- FIG. 6 is the view of FIG. 5 with the incision formation tool actuated to an open position to form a pocket for receiving the implant of FIG. 3 ;
- FIG. 6A is a view taken along line 6 A- 6 A in FIG. 6 ;
- FIG. 7 is the implant of FIG. 3 disposed on an implant insertion tool before final deployment;
- FIG. 8 is a view taken along line 8 - 8 of FIG. 7 ;
- FIG. 9 is the view of FIG. 7 with the implant insertion tool moved to an open position to fully place the implant within a pocket formed within the tongue;
- FIG. 10 is the view taken alone line 10 - 10 of FIG. 9 ;
- FIG. 11 is the top plan view of a tongue showing positioning of two implants within the tongue
- FIG. 12 is a view taken along line 12 - 12 of FIG. 11 ;
- FIG. 13 is a top plan view of a tongue showing an entire target region being stiffened
- FIG. 14 is the view of FIG. 1 showing the entire target region of FIG. 13 ;
- FIG. 15 is the view of FIG. 2 showing an alternative embodiment of an implant according to the present invention showing multiple implants in the tongue;
- FIG. 16 is a perspective view of a tubular implant used in the embodiment of FIG. 15 ;
- FIG. 16A is an end elevation view of the implant of FIG. 16 ;
- FIG. 17 is a top plant view of a tongue with implants of FIG. 16 arranged extending along an anterior-posterior axis of the tongue;
- FIG. 18 is the view of FIG. 17 with the implants disposed in the target region of FIG. 13 .
- FIG. 1 is a schematic representation of an upper airway of a patient.
- FIG. 1 shows the tongue T with a tongue base TB opposing a pharyngeal wall PW.
- the hard palate HP and soft palate SP reside over the top of tongue T with the soft palate SP extending rearward to a trailing end TE between the tongue base TB and the pharyngeal wall PW.
- a hyoid bone HB resides near the bottom of the tongue near an epiglottis E.
- a mandible or jaw bone JB is at the front of the tongue T.
- the geniohyoid muscle GH extends between the jaw bone JB and the hyoid bone HB at the bottom of the tongue T.
- the lines A of FIG. 1 illustrate the direction of muscle fibers in the geniohyoid muscle GH.
- the genioglossus muscle GG resides above the geniohyoid muscle GH.
- the genioglossus muscle GG has muscle fibers B which extend from the jaw bone JB and curve to radiate toward the surface of the tongue T.
- the tongue base TB When reclining during sleep, the tongue base TB may, in response to gravity or airflow, drop down in closer approximation to the pharyngeal wall PW.
- the muscles of the tongue T (principally the genioglossus muscle GG) can stretch permitting the tongue T to fall back toward the pharyngeal wall PW.
- the present invention is directed towards method and apparatus for stiffening the muscles of the tongue T in a manner to preclude the tongue T from falling toward the pharyngeal wall PW while avoiding interference with normal functions of the tongue T during speech and eating.
- FIG. 2 illustrates the present invention as an implant 10 placed within the interior of the tongue T.
- the implant 10 has a proximal end 12 and a distal end 14 .
- the implant 10 is a substantially planar sheet formed as a generally conical envelope best illustrated in FIG. 4 .
- the distal end 14 is the base of a cone with opposing edges of the base being stitched or otherwise bonded together so that the interior of the implant 10 is accessible only through the proximal end 12 .
- the implant 10 is a flat sheet with opposing surfaces of the cone compressed against one another.
- the implant 10 is sized to be received within the tongue T with the proximal end 12 positioned in a region of the tongue T adjacent the interface of the jaw JB and geniohyoid muscle GH.
- the height of the proximal end 12 (illustrated as H P in FIG. 3 ) is sized for the proximal end 12 to be received within the tongue T at the juncture of the jaw bone JB and the geniohyoid muscle GH.
- the implant 10 is further sized to have a length L for the distal end 14 to be positioned adjacent the tongue base TB in close proximity to the tongue base TB when the proximal end 12 is positioned in a region of the tongue T adjacent the interface of the jaw JB and geniohyoid muscle GH.
- the height of the distal end 14 (illustrated as H D in FIG. 3 ) is sized for the distal end 14 to extend within the tongue base TB substantially covering a region of the tongue base TB opposing the pharyngeal wall PW between the epiglottis E and the trailing end TE of the soft palate TB.
- representative dimensions for H P , H D and L are 1.0 centimeter, 2.5 centimeters and 4 centimeters, respectively.
- the fibrils of the material of implant 10 are about 20 microns to 100 microns in diameter. Depending on the braid or weave and the fibril diameter, the thickness of a sheet of the material may range from 50 to 500 microns.
- a double thickness TH ( FIG. 12 ) (which is transverse to the anterior-posterior axis of the tongue T following implantation) would be about 100 to 1000 microns.
- the material of the implant 10 is selected to produce a fibrotic response from the tissue of the tongue T following implantation of the implant 10 within the tongue T.
- the specific materials and construction may be varied to alter the degree of fibrotic response resulting from such implantation.
- the material of the implant 10 may be a knit or woven polyester or polypropylene material known to result in a fibrosis formation following implantation.
- FIGS. 5-10 illustrate a technique and tools for placement of the implant 10 within the tongue.
- a tool 20 is shown for forming an incision in the tongue T sized to receive the implant 10 .
- the tool 20 includes a curved handle 22 and a scissors end 24 .
- the scissors end 24 is hinged to the handle at hinge point 26 and includes a pair of scissor blades 28 , 30 (shown in FIG. 6 ).
- the tips 29 , 31 of the blades 30 , 28 are sharp to permit insertion of the tips 29 , 31 through tissue into the tongue T.
- the edges 27 , 33 of the blades 28 , 30 are sharp to permit slicing action of the scissor blades 28 , 30 through tissue.
- the blades 28 , 30 are collapsed so that they are in parallel alignment as shown in FIG. 5 .
- the tips 31 , 29 are passed through the patient's open mouth and are inserted into the tongue T at the front lower extremity of the tongue T just behind the jaw bone JB. Insertion is first made by urging the tips 29 , 31 downwardly into the region of interface between the geniohyoid muscle GH and the jaw bone JB and then curving the direction of travel upwardly to urge the tips 29 , 31 toward the tongue base TB.
- the scissor blades 28 , 30 are opened as shown in FIG. 6 to cut a pocket for receiving an implant 10 .
- the tool 20 is then removed.
- the arcuate nature of the handle 22 permits formation of an incision pocket extending from the geniohyoid muscle GH at the jaw JB toward the tongue base TB between the epiglottis E and the trailing end TE of the soft palate SP.
- Insertion tool 40 is similar in construction to the incision formation tool 20 . It includes a curved handle 42 and scissor action blades 44 , 46 . Unlike blades 28 , 30 , the blades 44 , 46 do not have knife edges in order to avoid damage to the implant 10 .
- the tips of the blades 44 , 46 are inserted into the interior of the implant 10 through the proximal end 12 .
- the implant 10 can then be folded surrounding the blades 44 , 46 into a compact configuration surrounding the blades 44 , 46 as shown in FIGS. 7 and 8 .
- the tool 40 carrying the implant 10 is placed into the incision pocket formed by tool 20 . Such positioning is shown in FIG. 7 .
- the blades 44 , 46 are actuated to an open position shown in FIG. 9 urging the implant 10 to its expanded state.
- the blades 44 , 46 can then be returned to their collapsed state and removed from the tongue T leaving the implant 10 in desired position within the tongue T.
- the proximal end 12 of the implant 10 be as positioned as close as possible to the jaw bone JB in the region of the geniohyoid muscle GH. If necessary, the surgeon can form additional incisions through the tongue T to pull the proximal end 12 into the geniohyoid muscle GH in close proximity to the jaw bone JB.
- FIG. 11 shows two implants 10 , 10 ′ positioned within the tongue T in the manner such as that previously described.
- the implants 10 , 10 ′ extend along the anterior posterior A-P axis.
- the proximal ends 12 , 12 ′ are positioned in close approximation to the anterior-posterior axis A-P.
- the implants 10 , 10 ′ do not extend straight back. Instead, they are angled outwardly toward the sides of the tongue T. As a result, the distal ends 14 , 14 ′ are spaced apart at opposite lateral extremities of the tongue base TB.
- a fibrotic capsule FC forms around the material of the implant 10 .
- the capsule FC is illustrated in FIG. 12 .
- the fibrotic capsule FC adds stiffness to the tissue of the tongue T.
- muscle fibers of the tongue are tendon-like.
- muscle fibers are less susceptible to stretching than the remainder of the length of the fibers. Since the fibrotic capsule FC and the proximal end 12 of the implant 10 originate in this region, a substantially non-stretchable region is formed in the tongue T by reason of the fibrotic capsule FC and the implant 10 .
- substantially the entire length of muscle fibers from the jaw bone JB to the tongue base TB can stretch during sleep resulting in the tongue base TB falling against the soft palate SP or pharyngeal wall PW during sleep.
- the implant 10 extending from the jaw bone JB to the tongue base TB, the muscle fibers in contact with the implant 10 and resulting fibrotic capsule FC are much less susceptible to stretching.
- FIG. 11 Use of two implants 10 , 10 ′ ( FIG. 11 ) forms two such non-stretchable planes within the tongue T.
- the placement of FIG. 11 ties the tongue base TB to the jaw bone JB with the lateral extremities of the tongue based TB being treated to resist stretching.
- a third implant could be placed along the anterior-posterior axis A-P to further resist tongue stretching.
- FIGS. 13 and 14 illustrate extreme treatments where the entire volume of the tongue from the mandibular-geniohyoid interface to the base of the tongue is stiffened.
- This volume V is illustrated in FIGS. 13 and 14 as a shaded area.
- the volume is defined as a generally conical volume having an apex at the mandibular-geniohyoid interface.
- the base of the conical volume is at the tongue base TB near the surface of the tongue and covering the portion of the tongue base TB opposing the pharyngeal wall PW between the epiglottis E and the training end TE of the soft palate SP.
- the volume V extends between the lateral extremities of the tongue base TB.
- Treatment of the entire volume can be accomplished by multiple implants 10 placed as described above.
- the volume V can be injected with any fibrosis-inducing agent (e.g., microbeads) throughout the volume V.
- any fibrosis-inducing agent e.g., microbeads
- the implant 10 will contract and expand with the muscle as it heals. Otherwise, a capsule surrounding the implant 10 will form as muscle slides over the implant 10 .
- This property is enabled by a combination of factors: the restoring force of the implant 10 , the friction against the tissue and attachments if any at either end.
- the mesh material of the implant 10 aids in achieving these objectives.
- the goal is to have an appropriate amount of spring tension/expansion and wall friction/in-growth such that the implant 10 contracts and expands with tissue. It is desirable to avoid an implant so stiff as to overly contract the muscle. This may cause the distal end of the implant to slide more proximal. As the scar forms and contracts, the implant contracts more permanently with the scar. This suggests the restoring force decreases over time.
- Biodegradable fibers suitable for this purpose or biodegradable coatings on the fibers themselves (which adhere the fibers together) may be used.
- the elastic properties of the implant should are approximately between 5 kPa to 50 kPa.
- the frictional force should be approximately 2N to 4 N. The patient's physiology and the size of the implant affect the range for these values.
- FIGS. 15-18 illustrate an alternative embodiment in which the target area or volume of the tongue is stiffened by placement of a plurality of tubular implants 10 ′′.
- One such implant 10 ′′ is separately shown in FIGS. 16 and 16A .
- the implant 10 ′′ is tube of polyester or other material selected to induce fibrosis following implantation in the tongue T.
- the implant 10 ′′ has a length L′ of 3-5 centimeters, an outside diameter D O of about 1 mm to 3 mm and an inside diameter D I resulting from a wall thickness of about 50 to 500 microns.
- Implants 10 ′′ for a single patient need not all be the same length L′. More interior implanted tubes 10 ′′ may be shorter so that proximal ends 12 ′′ do not impinge upon one another when multiple implants 10 ′′ are used (as will be described).
- the implant 10 ′′ may be placed with a proximal end 12 ′′ at the mandibular-geniohyoid interface and with a distal end 14 ′′ at the tongue base TB.
- FIG. 15 shows three such implants 10 ′′ disposed in a vertical planar array 16 ′′ substantially filling the plane of implant 10 of FIG. 2 .
- a single such array 16 ′′ may be positioned in line with the anterior posterior axis A-P (as shown in FIG. 17 ) or multiple such arrays 16 ′′ may be positioned similar to the positioning of implants 10 in FIG. 11 (as illustrated in FIG. 18 ).
- Use of tubular implant 10 ′′ permits a more uniform distribution of implants in the target volume V and creation of a filled target volume of more conical shape.
- the insertion tool for the tube shaped implants 10 ′′ may be much like the insertion tool described in U.S. patent application Publication No. 2005/0154412 A1 (incorporated herein by reference) which describes a tool for placing a solid braided implant such as that marketed by assignee of the present application (Restore Medical Inc., St. Paul, Minn., USA) under the trademark “Pillar”.
- the tool may be modified to replace the needle of the tool with a rod received within the implant 10 ′′ through the proximal end 12 ′′.
- the rod may extend to the distal tip 14 ′′ of the implant 10 ′′. Retracting the rod leaves the implant 10 ′′ in desired position in the tongue T.
- no stiffening treatment is made in the tongue T in the upper region of the tongue T.
- this region of the tongue T is active in speech and swallowing. Since no treatment is made in this region, these functions are not impaired.
Abstract
A patient's obstructive sleep apnea is treated by identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient. The method includes identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue and stiffening a tissue of the tongue throughout the identified region.
Description
- 1. Field of the Invention
- This invention pertains to a method for treating a condition of an upper airway of a patient. More particularly, this invention is directed to a method for treating obstructive sleep apnea by stiffening a tongue of a patient.
- 2. Description of the Prior Art
- Upper airway conditions such as obstructive sleep apnea (“OSA”) and snoring have received a great deal of attention. These conditions have recognized sociological and health implications for both the patient and the patient's bed partner.
- Numerous attempts have been made towards treating OSA and snoring. These include placing implants in either the tissue of the soft palate or the pharyngeal airway as disclosed in commonly assigned U.S. Pat. No. 6,250,307 to Conrad et al. dated Jun. 26, 2003, U.S. Pat. No. 6,523,542 to Metzger et al. dated Feb. 25, 2003 and U.S. Pat. No. 6,431,174 to Knudson et al. dated Aug. 13, 2002. Further, U.S. Pat. No. 6,601,584 to Knudson et al. dated Aug. 5, 2003 teaches a contracting implant for placement in the soft palate of the patient.
- Another prior art technique for treating OSA or snoring is disclosed in U.S. Pat. No. 5,988,171 to Sohn et al. dated Nov. 23, 1999. In the '171 patent, a cord (e.g., a suture material) (element 32 in FIG. 6 of the '171 patent) is placed surrounding a base of the tongue and secured to the jaw by reason at an attachment member (
element 20 in FIG. 6 of the '171 patent). In the method of the '171 patent, the member 32 can be shortened to draw the base of the tongue toward the jaw and thereby move the tissue of the base of the tongue away from the opposing tissue of the pharyngeal airway. However, this procedure is often uncomfortable. This procedure, referred to as tongue suspension, is also described in Miller et al., “Role of the tongue base suspension suture with The Repose System bone screw in the multilevel surgical management of obstructive sleep apnea”, Otolaryngol. Head Neck Surg., Vol. 126, pp. 392-398 (2002). - Another technique includes debulking tissue by applying radio frequency ablation to either the tongue base or of the soft palate to debulk the tissue of the tongue or palate, respectively. This technique is illustrated in U.S. Pat. No. 5,843,021 to Edwards et al. dated Dec. 1, 1998. RF tongue base reduction procedures are described in Powell et al., “Radiofrequency tongue base reduction in sleep-disordered breathing: A pilot study”, Otolaryngol. Head Neck Surg., Vol. 120, pp. 656-664. (1999) and Powell et al., “Radiofrequency Volumetric Reduction of the Tongue—A Porcine Pilot Study for the Treatment of Obstructive Sleep Apnea Syndrome”, Chest, Vol. 111, pp. 1348-1355 (1997).
- A surgical hyoid expansion to treat OSA is disclosed in U.S. Pat. No. 6,161,541 to Woodson dated Dec. 19, 2000. Other tongue treatments for OSA include stimulation of the hypoglossal nerve. This procedure is described in Eisle et al., “Direct Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea”, Arch. Otolaryngol. Head Neck Surg., Vol. 123, pp. 57-61 (1997).
- Commonly assigned U.S. patent applications Publication Nos. US 2005/0092332 A1 and US 2005/0092334 A1 (both published May 5, 2005) describe tongue-based treatments to treat obstructive sleep apnea. U.S. patent application Ser. Nos. 11/107,160 and 11/107,161 (both filed Apr. 15, 2005 and assigned to the assignee of the present invention) describe various implants for a tongue to treat obstructive sleep apnea.
- European Patent EP 1,039,859 B1 granted Dec. 3, 2003 describes a brace placed in the tongue. German Patent No. 19 920 114 describes struts in pharyngeal wall. U.S. patent applications Publication Nos. US 2005/0126563 A1 published Jun. 16, 2005 and US 2005/0199248 A1 published Sep. 15, 2005 describe stents in an airway. U.S. patent applications Publication Nos. US 2004/0139975 published Jul. 22, 2004 and US 2004/0149290 published Aug. 5, 2005 (both assigned to Apneon Inc.) describe struts or magnets in the tongue.
- According to a preferred embodiment, obstructive sleep apnea of a patient is treated by identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient. The method includes identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue and stiffening a tissue of the tongue throughout the identified region.
-
FIG. 1 is a side sectional schematic view of an upper airway of a patient and illustrating various anatomical features; -
FIG. 2 is the view ofFIG. 1 showing an implant of the present invention placed within the tongue according to a treatment method of the present invention; -
FIG. 3 is a side elevation view of the implant ofFIG. 1 ; -
FIG. 4 is a perspective view of the implant ofFIG. 3 ; -
FIG. 5 is the view ofFIG. 1 showing an incision formation tool placed within the tongue; -
FIG. 6 is the view ofFIG. 5 with the incision formation tool actuated to an open position to form a pocket for receiving the implant ofFIG. 3 ; -
FIG. 6A is a view taken alongline 6A-6A inFIG. 6 ; -
FIG. 7 is the implant ofFIG. 3 disposed on an implant insertion tool before final deployment; -
FIG. 8 is a view taken along line 8-8 ofFIG. 7 ; -
FIG. 9 is the view ofFIG. 7 with the implant insertion tool moved to an open position to fully place the implant within a pocket formed within the tongue; -
FIG. 10 is the view taken alone line 10-10 ofFIG. 9 ; -
FIG. 11 is the top plan view of a tongue showing positioning of two implants within the tongue; -
FIG. 12 is a view taken along line 12-12 ofFIG. 11 ; -
FIG. 13 is a top plan view of a tongue showing an entire target region being stiffened; -
FIG. 14 is the view ofFIG. 1 showing the entire target region ofFIG. 13 ; -
FIG. 15 is the view ofFIG. 2 showing an alternative embodiment of an implant according to the present invention showing multiple implants in the tongue; -
FIG. 16 is a perspective view of a tubular implant used in the embodiment ofFIG. 15 ; -
FIG. 16A is an end elevation view of the implant ofFIG. 16 ; -
FIG. 17 is a top plant view of a tongue with implants ofFIG. 16 arranged extending along an anterior-posterior axis of the tongue; and -
FIG. 18 is the view ofFIG. 17 with the implants disposed in the target region ofFIG. 13 . - With reference now to the various drawing figures in which identical elements are numbered identically throughout, a description of the preferred embodiment of the present invention will now be provided.
-
FIG. 1 is a schematic representation of an upper airway of a patient.FIG. 1 shows the tongue T with a tongue base TB opposing a pharyngeal wall PW. The hard palate HP and soft palate SP reside over the top of tongue T with the soft palate SP extending rearward to a trailing end TE between the tongue base TB and the pharyngeal wall PW. - A hyoid bone HB resides near the bottom of the tongue near an epiglottis E. A mandible or jaw bone JB is at the front of the tongue T. The geniohyoid muscle GH extends between the jaw bone JB and the hyoid bone HB at the bottom of the tongue T. The lines A of
FIG. 1 illustrate the direction of muscle fibers in the geniohyoid muscle GH. The genioglossus muscle GG resides above the geniohyoid muscle GH. The genioglossus muscle GG has muscle fibers B which extend from the jaw bone JB and curve to radiate toward the surface of the tongue T. - When reclining during sleep, the tongue base TB may, in response to gravity or airflow, drop down in closer approximation to the pharyngeal wall PW. During sleep, the muscles of the tongue T (principally the genioglossus muscle GG) can stretch permitting the tongue T to fall back toward the pharyngeal wall PW.
- The present invention is directed towards method and apparatus for stiffening the muscles of the tongue T in a manner to preclude the tongue T from falling toward the pharyngeal wall PW while avoiding interference with normal functions of the tongue T during speech and eating.
-
FIG. 2 illustrates the present invention as animplant 10 placed within the interior of the tongue T. Theimplant 10 has aproximal end 12 and adistal end 14. In a preferred embodiment, theimplant 10 is a substantially planar sheet formed as a generally conical envelope best illustrated inFIG. 4 . Thedistal end 14 is the base of a cone with opposing edges of the base being stitched or otherwise bonded together so that the interior of theimplant 10 is accessible only through theproximal end 12. Theimplant 10 is a flat sheet with opposing surfaces of the cone compressed against one another. - The
implant 10 is sized to be received within the tongue T with theproximal end 12 positioned in a region of the tongue T adjacent the interface of the jaw JB and geniohyoid muscle GH. The height of the proximal end 12 (illustrated as HP inFIG. 3 ) is sized for theproximal end 12 to be received within the tongue T at the juncture of the jaw bone JB and the geniohyoid muscle GH. Theimplant 10 is further sized to have a length L for thedistal end 14 to be positioned adjacent the tongue base TB in close proximity to the tongue base TB when theproximal end 12 is positioned in a region of the tongue T adjacent the interface of the jaw JB and geniohyoid muscle GH. The height of the distal end 14 (illustrated as HD inFIG. 3 ) is sized for thedistal end 14 to extend within the tongue base TB substantially covering a region of the tongue base TB opposing the pharyngeal wall PW between the epiglottis E and the trailing end TE of the soft palate TB. By way of non-limiting example, representative dimensions for HP, HD and L are 1.0 centimeter, 2.5 centimeters and 4 centimeters, respectively. The fibrils of the material ofimplant 10 are about 20 microns to 100 microns in diameter. Depending on the braid or weave and the fibril diameter, the thickness of a sheet of the material may range from 50 to 500 microns. A double thickness TH (FIG. 12 ) (which is transverse to the anterior-posterior axis of the tongue T following implantation) would be about 100 to 1000 microns. - The material of the
implant 10 is selected to produce a fibrotic response from the tissue of the tongue T following implantation of theimplant 10 within the tongue T. The specific materials and construction may be varied to alter the degree of fibrotic response resulting from such implantation. By way of non-limiting example, the material of theimplant 10 may be a knit or woven polyester or polypropylene material known to result in a fibrosis formation following implantation. -
FIGS. 5-10 illustrate a technique and tools for placement of theimplant 10 within the tongue. InFIG. 5 , atool 20 is shown for forming an incision in the tongue T sized to receive theimplant 10. Thetool 20 includes a curved handle 22 and ascissors end 24. The scissors end 24 is hinged to the handle athinge point 26 and includes a pair ofscissor blades 28, 30 (shown inFIG. 6 ). Thetips 29, 31 of theblades tips 29, 31 through tissue into the tongue T. Further, theedges blades scissor blades - In use, the
blades FIG. 5 . Thetips 31, 29 are passed through the patient's open mouth and are inserted into the tongue T at the front lower extremity of the tongue T just behind the jaw bone JB. Insertion is first made by urging thetips 29, 31 downwardly into the region of interface between the geniohyoid muscle GH and the jaw bone JB and then curving the direction of travel upwardly to urge thetips 29, 31 toward the tongue base TB. - When the
tool 20 is in the position ofFIG. 5 , thescissor blades FIG. 6 to cut a pocket for receiving animplant 10. Thetool 20 is then removed. The arcuate nature of the handle 22 permits formation of an incision pocket extending from the geniohyoid muscle GH at the jaw JB toward the tongue base TB between the epiglottis E and the trailing end TE of the soft palate SP. - Following formation of the pocket, an
insertion tool 40 is provided as illustrated inFIG. 7 .Insertion tool 40 is similar in construction to theincision formation tool 20. It includes acurved handle 42 andscissor action blades blades blades implant 10. - With the
blades FIGS. 7 and 8 , the tips of theblades implant 10 through theproximal end 12. Theimplant 10 can then be folded surrounding theblades blades FIGS. 7 and 8 . Thetool 40 carrying theimplant 10 is placed into the incision pocket formed bytool 20. Such positioning is shown inFIG. 7 . After such positioning, theblades FIG. 9 urging theimplant 10 to its expanded state. Theblades implant 10 in desired position within the tongue T. - As mentioned, it is desired that the
proximal end 12 of theimplant 10 be as positioned as close as possible to the jaw bone JB in the region of the geniohyoid muscle GH. If necessary, the surgeon can form additional incisions through the tongue T to pull theproximal end 12 into the geniohyoid muscle GH in close proximity to the jaw bone JB. -
FIG. 11 shows twoimplants implants implants - Following implantation, a fibrotic capsule FC forms around the material of the
implant 10. The capsule FC is illustrated inFIG. 12 . The fibrotic capsule FC adds stiffness to the tissue of the tongue T. - At the juncture of the geniohyoid muscle GH and the jaw bone JB (referred to herein as the “mandibular-geniohyoid interface”, muscle fibers of the tongue are tendon-like. By “tendon-like”, it is meant the muscle fibers are less susceptible to stretching than the remainder of the length of the fibers. Since the fibrotic capsule FC and the
proximal end 12 of theimplant 10 originate in this region, a substantially non-stretchable region is formed in the tongue T by reason of the fibrotic capsule FC and theimplant 10. - In the absence of an
implant 10, substantially the entire length of muscle fibers from the jaw bone JB to the tongue base TB can stretch during sleep resulting in the tongue base TB falling against the soft palate SP or pharyngeal wall PW during sleep. With theimplant 10 extending from the jaw bone JB to the tongue base TB, the muscle fibers in contact with theimplant 10 and resulting fibrotic capsule FC are much less susceptible to stretching. - Use of two
implants FIG. 11 ) forms two such non-stretchable planes within the tongue T. The placement ofFIG. 11 ties the tongue base TB to the jaw bone JB with the lateral extremities of the tongue based TB being treated to resist stretching. If desired, a third implant could be placed along the anterior-posterior axis A-P to further resist tongue stretching. -
FIGS. 13 and 14 illustrate extreme treatments where the entire volume of the tongue from the mandibular-geniohyoid interface to the base of the tongue is stiffened. This volume V is illustrated inFIGS. 13 and 14 as a shaded area. The volume is defined as a generally conical volume having an apex at the mandibular-geniohyoid interface. The base of the conical volume is at the tongue base TB near the surface of the tongue and covering the portion of the tongue base TB opposing the pharyngeal wall PW between the epiglottis E and the training end TE of the soft palate SP. The volume V extends between the lateral extremities of the tongue base TB. - Treatment of the entire volume can be accomplished by
multiple implants 10 placed as described above. Alternatively, the volume V can be injected with any fibrosis-inducing agent (e.g., microbeads) throughout the volume V. - Ideally, the
implant 10 will contract and expand with the muscle as it heals. Otherwise, a capsule surrounding theimplant 10 will form as muscle slides over theimplant 10. This property is enabled by a combination of factors: the restoring force of theimplant 10, the friction against the tissue and attachments if any at either end. The mesh material of theimplant 10 aids in achieving these objectives. The goal is to have an appropriate amount of spring tension/expansion and wall friction/in-growth such that theimplant 10 contracts and expands with tissue. It is desirable to avoid an implant so stiff as to overly contract the muscle. This may cause the distal end of the implant to slide more proximal. As the scar forms and contracts, the implant contracts more permanently with the scar. This suggests the restoring force decreases over time. Biodegradable fibers suitable for this purpose or biodegradable coatings on the fibers themselves (which adhere the fibers together) may be used. The elastic properties of the implant should are approximately between 5 kPa to 50 kPa. The frictional force should be approximately 2N to 4 N. The patient's physiology and the size of the implant affect the range for these values. -
FIGS. 15-18 illustrate an alternative embodiment in which the target area or volume of the tongue is stiffened by placement of a plurality oftubular implants 10″. Onesuch implant 10″ is separately shown inFIGS. 16 and 16A . In a representative embodiment, theimplant 10″ is tube of polyester or other material selected to induce fibrosis following implantation in the tongue T. Theimplant 10″ has a length L′ of 3-5 centimeters, an outside diameter DO of about 1 mm to 3 mm and an inside diameter DI resulting from a wall thickness of about 50 to 500 microns.Implants 10″ for a single patient need not all be the same length L′. More interior implantedtubes 10″ may be shorter so that proximal ends 12″ do not impinge upon one another whenmultiple implants 10″ are used (as will be described). - The
implant 10″ may be placed with aproximal end 12″ at the mandibular-geniohyoid interface and with adistal end 14″ at the tongue base TB.FIG. 15 shows threesuch implants 10″ disposed in a verticalplanar array 16″ substantially filling the plane ofimplant 10 ofFIG. 2 . A singlesuch array 16″ may be positioned in line with the anterior posterior axis A-P (as shown inFIG. 17 ) or multiplesuch arrays 16″ may be positioned similar to the positioning ofimplants 10 inFIG. 11 (as illustrated inFIG. 18 ). Use oftubular implant 10″ permits a more uniform distribution of implants in the target volume V and creation of a filled target volume of more conical shape. - The insertion tool for the tube shaped
implants 10″ may be much like the insertion tool described in U.S. patent application Publication No. 2005/0154412 A1 (incorporated herein by reference) which describes a tool for placing a solid braided implant such as that marketed by assignee of the present application (Restore Medical Inc., St. Paul, Minn., USA) under the trademark “Pillar”. The tool may be modified to replace the needle of the tool with a rod received within theimplant 10″ through theproximal end 12″. The rod may extend to thedistal tip 14″ of theimplant 10″. Retracting the rod leaves theimplant 10″ in desired position in the tongue T. - In the foregoing example, no stiffening treatment is made in the tongue T in the upper region of the tongue T. Generally defined herein as the region of the tongue T above and forward of a line from the jaw bone JD to the trailing end of the hard palate HP, this region of the tongue T is active in speech and swallowing. Since no treatment is made in this region, these functions are not impaired.
- It has been shown how the present invention has been obtained in a preferred embodiment. Modifications and equivalents of the disclosed concepts are intended to be included within the scope of the claims which are appended hereto.
Claims (9)
1. A method for treating obstructive sleep apnea comprising:
identifying a patient with sleep apnea attributable at least in part to movement of a base of a tongue of said patient toward a pharyngeal wall of said patient;
identifying a region in the tongue extending from a mandibular-geniohyoid interface to the base of the tongue;
stiffening a tissue of the tongue throughout the identified region.
2. A method according to claim 1 wherein the identified region includes an area of the base of the tongue opposing the pharyngeal wall between an epiglottis and a trailing end of a soft palate.
3. A method according to claim 1 wherein the identified region includes an area of the base of the tongue between lateral extremities of the base of the tongue.
4. A method according to claim 1 wherein said stiffening includes placing an implant of fibrosis-inducing material within the tongue with the implant extending throughout said region with the material selected to induce formation of fibrosis along said region.
5. A method according to claim 4 wherein said implant is sized for said region to extend substantially between an epiglottis and a soft palate of the patient at the base of the tongue.
6. A method according to claim 5 wherein said implant is a substantially planar sheet placed in the tongue with a narrow dimension extending transverse to the tongue and having a proximal end within said region at said mandibular-geniohyoid interface and with a distal end within the tongue at the base and extending between the epiglottis and the soft palate.
7. A method according to FIG. 4 wherein said implant is a tubular material selected to induce fibrosis formation and with a proximal end at said mandibular-geniohyoid interface and with a distal end at said base of the tongue.
8. A method according to claim 7 wherein said region includes an area of the base of the tongue between lateral extremities of the base of the tongue and said method includes placing multiples of said implants in a volume of said tongue within said region.
9. A method according to claim 1 according to claim 4 wherein said material is selected for said implant to contract and expand with the tongue as the tongue heals.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/542,455 US20080078411A1 (en) | 2006-10-03 | 2006-10-03 | Tongue implant for sleep apnea |
US11/706,729 US20080078412A1 (en) | 2006-10-03 | 2007-02-15 | Tongue implant |
PCT/US2007/018778 WO2008042058A1 (en) | 2006-10-03 | 2007-08-24 | Tongue implant |
JP2009531373A JP5254981B2 (en) | 2006-10-03 | 2007-08-24 | Tongue implant |
CA2665525A CA2665525C (en) | 2006-10-03 | 2007-08-24 | Tongue implant |
CN200780042589XA CN101677871B (en) | 2006-10-03 | 2007-08-24 | Tongue implant |
KR1020097009282A KR101411075B1 (en) | 2006-10-03 | 2007-08-24 | Tongue implant |
EP07837335A EP2091477A1 (en) | 2006-10-03 | 2007-08-24 | Tongue implant |
US12/553,262 US7845357B2 (en) | 2006-10-03 | 2009-09-03 | Tongue implant for sleep apnea |
US12/586,170 US8381735B2 (en) | 2006-10-03 | 2009-09-16 | Tongue implant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/542,455 US20080078411A1 (en) | 2006-10-03 | 2006-10-03 | Tongue implant for sleep apnea |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/706,729 Continuation-In-Part US20080078412A1 (en) | 2006-10-03 | 2007-02-15 | Tongue implant |
US12/553,262 Continuation US7845357B2 (en) | 2006-10-03 | 2009-09-03 | Tongue implant for sleep apnea |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080078411A1 true US20080078411A1 (en) | 2008-04-03 |
Family
ID=39272831
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/542,455 Abandoned US20080078411A1 (en) | 2006-10-03 | 2006-10-03 | Tongue implant for sleep apnea |
US12/553,262 Active US7845357B2 (en) | 2006-10-03 | 2009-09-03 | Tongue implant for sleep apnea |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/553,262 Active US7845357B2 (en) | 2006-10-03 | 2009-09-03 | Tongue implant for sleep apnea |
Country Status (1)
Country | Link |
---|---|
US (2) | US20080078411A1 (en) |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080261886A1 (en) * | 2001-07-16 | 2008-10-23 | Novo Nordisk Healthcare A/G | Single-Dose Administration of Factor VIIa |
US20090177027A1 (en) * | 2008-01-03 | 2009-07-09 | Gillis Edward M | Partially erodable systems for treatment of obstructive sleep apnea |
US20100024830A1 (en) * | 2008-07-30 | 2010-02-04 | Ethicon, Inc. | Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea |
US20100030011A1 (en) * | 2008-07-31 | 2010-02-04 | Ethicon, Inc. | Magnetic implants for treating obstructive sleep apnea and methods therefor |
US20100037901A1 (en) * | 2008-08-14 | 2010-02-18 | Rousseau Robert A | Methods and devices for treatment of obstructive sleep apnea |
US20100108077A1 (en) * | 2008-10-30 | 2010-05-06 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US20100132719A1 (en) * | 2008-12-01 | 2010-06-03 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US20100163056A1 (en) * | 2008-12-30 | 2010-07-01 | Medartis Ag | Implant |
US20100294284A1 (en) * | 2008-12-09 | 2010-11-25 | H-Medical | Apparatus, systems, and methods for constraining and/or supporting tissue structures along an airway |
US20110100378A1 (en) * | 2009-10-30 | 2011-05-05 | Ethicon, Inc. | Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea |
WO2011059629A1 (en) * | 2009-10-29 | 2011-05-19 | Ethicon, Inc. | Tongue suspension system with hyoid-extender for treating obstructive sleep apnea |
US20110226263A1 (en) * | 2010-03-19 | 2011-09-22 | Gillis Edward M | Systems and methods for treatment of sleep apnea |
US20110226262A1 (en) * | 2010-03-19 | 2011-09-22 | Gillis Edward M | Systems and methods for treatment of sleep apnea |
US8307831B2 (en) | 2009-03-16 | 2012-11-13 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8327854B2 (en) | 2008-05-12 | 2012-12-11 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US8561616B2 (en) | 2008-10-24 | 2013-10-22 | Ethicon, Inc. | Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea |
US20140007885A1 (en) * | 2012-07-06 | 2014-01-09 | Edward M. Gillis | Systems and methods for treatment of sleep apnea |
US8632488B2 (en) | 2009-12-15 | 2014-01-21 | Ethicon, Inc. | Fluid filled implants for treating medical conditions |
US8800567B2 (en) | 2008-12-01 | 2014-08-12 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8813754B2 (en) | 2009-02-17 | 2014-08-26 | Ethicon, Inc. | Magnetic implants and methods for treating an oropharyngeal condition |
US8905033B2 (en) | 2011-09-28 | 2014-12-09 | Ethicon, Inc. | Modular tissue securement systems |
US8973582B2 (en) | 2011-11-30 | 2015-03-10 | Ethicon, Inc. | Tongue suspension device and method |
US9161855B2 (en) | 2011-10-24 | 2015-10-20 | Ethicon, Inc. | Tissue supporting device and method |
US9173766B2 (en) | 2012-06-01 | 2015-11-03 | Ethicon, Inc. | Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients |
US9326886B2 (en) | 2009-10-29 | 2016-05-03 | Ethicon, Inc. | Fluid filled implants for treating obstructive sleep apnea |
US9439801B2 (en) | 2012-06-29 | 2016-09-13 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US9510922B2 (en) | 2010-05-21 | 2016-12-06 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US9643022B2 (en) | 2013-06-17 | 2017-05-09 | Nyxoah SA | Flexible control housing for disposable patch |
US9707122B2 (en) | 2010-07-26 | 2017-07-18 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US9849289B2 (en) | 2009-10-20 | 2017-12-26 | Nyxoah SA | Device and method for snoring detection and control |
US9855032B2 (en) | 2012-07-26 | 2018-01-02 | Nyxoah SA | Transcutaneous power conveyance device |
US9943686B2 (en) | 2009-10-20 | 2018-04-17 | Nyxoah SA | Method and device for treating sleep apnea based on tongue movement |
US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
US10314736B2 (en) | 2012-10-16 | 2019-06-11 | Cook Medical Technologies Llc | Method and apparatus for treating obstructive sleep apnea (OSA) |
US10470760B2 (en) | 2011-12-08 | 2019-11-12 | Ethicon, Inc. | Modified tissue securement fibers |
US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
US10814137B2 (en) | 2012-07-26 | 2020-10-27 | Nyxoah SA | Transcutaneous power conveyance device |
US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9415216B2 (en) | 2009-10-20 | 2016-08-16 | Nyxoah SA | Devices for treatment of sleep apnea |
EP2731561B1 (en) | 2011-07-14 | 2016-03-23 | Cook Medical Technologies LLC | A sling to be used in the treatment of obstructive sleep apnea |
CA2850444A1 (en) | 2011-09-30 | 2013-04-25 | Adi Mashiach | Apparatus and method to control an implant |
US10123900B2 (en) | 2013-03-15 | 2018-11-13 | Cook Medical Technologies Llc | Devices, kits, and methods for the treatment of obstructive sleep apnea |
CA2919504A1 (en) | 2013-08-01 | 2015-02-05 | Christine BRONIKOWSKI | Tissue adjustment implant |
JP6364078B2 (en) | 2013-08-05 | 2018-07-25 | クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーCook Medical Technologies Llc | Medical device having releasable tubular member and method of using the same |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US9974563B2 (en) | 2014-05-28 | 2018-05-22 | Cook Medical Technologies Llc | Medical devices having a releasable member and methods of using the same |
WO2016022454A1 (en) | 2014-08-04 | 2016-02-11 | Darin Schaeffer | Medical devices having a releasable tubular member and methods of using the same |
EP3644911A1 (en) | 2017-06-29 | 2020-05-06 | Cook Medical Technologies, LLC | Implantable medical devices for tissue repositioning |
US11198002B2 (en) | 2020-01-24 | 2021-12-14 | Medtronic Xomed, Inc. | Needle and introducer used in lead placement for obstructive sleep apnea treatment |
US11666751B2 (en) | 2020-01-24 | 2023-06-06 | Medtronic Xomed, Inc. | Combination obstructive sleep apnea trialing lead and chronic lead |
US11273305B2 (en) | 2020-01-24 | 2022-03-15 | Medtronic Xomed, Inc. | Medical lead for treating obstructive sleep apnea (OSA) with electrical stimulation |
US11426201B2 (en) | 2020-01-24 | 2022-08-30 | Medtronic Xomed, Inc. | Treatment of obstructive sleep apnea (OSA) |
US11819233B2 (en) | 2020-01-24 | 2023-11-21 | Medtronic Xomed, Inc. | Devices and techniques for separating tissue |
US11806272B2 (en) | 2020-03-04 | 2023-11-07 | Randall Ow | Devices and methods for treating obstructive breathing disorders |
Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4193137A (en) * | 1977-05-06 | 1980-03-18 | Meadox Medicals, Inc. | Warp-knitted double-velour prosthesis |
US4347847A (en) * | 1980-06-06 | 1982-09-07 | Usher Francis C | Method of hernia repair |
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4672673A (en) * | 1982-11-01 | 1987-06-09 | Thomas Jefferson University | Artificial larynx |
US5258000A (en) * | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
US5522896A (en) * | 1989-02-15 | 1996-06-04 | Xomed, Inc. | Biocompatible composite material |
US5843021A (en) * | 1994-05-09 | 1998-12-01 | Somnus Medical Technologies, Inc. | Cell necrosis apparatus |
US5988171A (en) * | 1997-06-26 | 1999-11-23 | Influence Medical Technologies, Ltd. | Methods and devices for the treatment of airway obstruction, sleep apnea and snoring |
US6161541A (en) * | 1998-06-09 | 2000-12-19 | Influent Ltd. | Hyoid expansion and suspension procedure |
US6250307B1 (en) * | 1999-09-17 | 2001-06-26 | Pi Medical, Inc. | Snoring treatment |
US6413254B1 (en) * | 2000-01-19 | 2002-07-02 | Medtronic Xomed, Inc. | Method of tongue reduction by thermal ablation using high intensity focused ultrasound |
US20020083820A1 (en) * | 2000-10-10 | 2002-07-04 | Greenhalgh E. Skott | Stiffened fabric |
US6431174B1 (en) * | 2000-08-10 | 2002-08-13 | Pi Medical, Inc. | Method and apparatus to treat conditions of the naso-pharyngeal area |
US6513530B2 (en) * | 1999-09-17 | 2003-02-04 | Pi Medical, Inc. | Braided palatal implant for snoring treatment |
US6523541B2 (en) * | 1999-09-17 | 2003-02-25 | Pi Medical, Inc. | Delivery system for snoring treatment implant and method |
US6523542B2 (en) * | 1999-09-17 | 2003-02-25 | Pi Medical, Inc. | Snoring treatment implant and method |
US6601584B2 (en) * | 1999-09-17 | 2003-08-05 | Pi Medical, Inc. | Contracting snoring treatment implant |
US20040020492A1 (en) * | 2002-05-02 | 2004-02-05 | Dubrul William R. | Upper airway device and method |
US20040028676A1 (en) * | 2002-08-06 | 2004-02-12 | Klein Dean A. | Swallowing system tissue modifier |
US20040045556A1 (en) * | 2002-09-06 | 2004-03-11 | Swan Medical | Systems and methods for moving and/or restraining tissue in the upper respiratory system |
US6736823B2 (en) * | 2002-05-10 | 2004-05-18 | C.R. Bard, Inc. | Prosthetic repair fabric |
US20040134491A1 (en) * | 2002-12-30 | 2004-07-15 | Quiescence Medical | Apparatus and methods for treating sleep apnea |
US20040139975A1 (en) * | 2002-09-06 | 2004-07-22 | Apneon, Inc. | Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit |
US20040149290A1 (en) * | 2002-09-06 | 2004-08-05 | Apneon, Inc. | Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit |
US20050004417A1 (en) * | 2002-09-06 | 2005-01-06 | Apneon, Inc. | Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit |
US20050092334A1 (en) * | 2003-10-31 | 2005-05-05 | Restore Medical, Inc. | Airway implant |
US20050092332A1 (en) * | 2003-10-31 | 2005-05-05 | Restore Medical, Inc. | Airway implant |
US20050126563A1 (en) * | 2003-12-15 | 2005-06-16 | Van Der Burg Erik J. | System and method for hyoidplasty |
US20050142163A1 (en) * | 2003-11-10 | 2005-06-30 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US20050154412A1 (en) * | 2003-09-19 | 2005-07-14 | Restore Medical, Inc. | Airway implant and delivery tool |
US6918396B1 (en) * | 1998-12-01 | 2005-07-19 | Purdue Research Foundation | Method for vocal cord reconstruction |
US6955172B2 (en) * | 2002-09-06 | 2005-10-18 | Apneon, Inc. | Systems and methods for moving and/or restraining the tongue in the oral cavity |
US20050267321A1 (en) * | 2004-06-01 | 2005-12-01 | Shadduck John H | Elastomeric magnetic nanocomposite biomedical devices |
US20050281883A1 (en) * | 2004-04-28 | 2005-12-22 | Daniloff George Y | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
US20060029591A1 (en) * | 1998-10-06 | 2006-02-09 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
US6997956B2 (en) * | 1999-10-20 | 2006-02-14 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US20060070626A1 (en) * | 2004-10-04 | 2006-04-06 | Andrew Frazier | System and method for airway manipulation |
US7048753B2 (en) * | 1999-03-17 | 2006-05-23 | Poly-Med, Inc. | Coated, slow-absorbing textile constructs for sutures and tissue engineering |
US7073505B2 (en) * | 2002-09-06 | 2006-07-11 | Apneon, Inc. | Systems and methods for moving and/or restraining tissue in the oral cavity |
US20060153816A1 (en) * | 2003-06-27 | 2006-07-13 | Laura Brown | Soft tissue repair and regeneration using postpartum-derived cells and cell products |
US7078378B1 (en) * | 1998-06-18 | 2006-07-18 | Avastra Ltd. | Method of tissue repair II |
US7081086B2 (en) * | 2000-03-10 | 2006-07-25 | Paracor Medical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US20060235264A1 (en) * | 2005-04-15 | 2006-10-19 | Restore Medical, Inc. | Implant for tongue |
US20060235380A1 (en) * | 2005-04-15 | 2006-10-19 | Restore Medical, Inc. | Tissue incision tool |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19756956C1 (en) | 1997-12-20 | 1999-07-15 | Wolfgang Dr Med Fege | Implant for implantation in a tongue |
DE19920114A1 (en) | 1999-05-03 | 2000-11-09 | Fege Wolfgang | Throat side implant |
AU8038700A (en) | 1999-09-17 | 2001-04-17 | Pi Medical, Inc. | Implants and methods for snoring treatment |
JP2002315293A (en) * | 2001-04-11 | 2002-10-25 | Nidec Copal Corp | Actuator |
DE10217350C1 (en) | 2002-04-18 | 2003-12-18 | Mnemoscience Gmbh | polyesterurethanes |
CN1702849A (en) * | 2004-05-26 | 2005-11-30 | 松下电器产业株式会社 | Temperature abnormality detection method and semiconductor manufacturing apparatus |
DE102005000702B4 (en) | 2005-01-04 | 2007-08-23 | Klinikum Der Universität Regensburg | Device for central implantation in a tongue body |
-
2006
- 2006-10-03 US US11/542,455 patent/US20080078411A1/en not_active Abandoned
-
2009
- 2009-09-03 US US12/553,262 patent/US7845357B2/en active Active
Patent Citations (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4193137A (en) * | 1977-05-06 | 1980-03-18 | Meadox Medicals, Inc. | Warp-knitted double-velour prosthesis |
US4347847A (en) * | 1980-06-06 | 1982-09-07 | Usher Francis C | Method of hernia repair |
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4655771B1 (en) * | 1982-04-30 | 1996-09-10 | Medinvent Ams Sa | Prosthesis comprising an expansible or contractile tubular body |
US4672673A (en) * | 1982-11-01 | 1987-06-09 | Thomas Jefferson University | Artificial larynx |
US5522896A (en) * | 1989-02-15 | 1996-06-04 | Xomed, Inc. | Biocompatible composite material |
US5578086A (en) * | 1989-02-15 | 1996-11-26 | Xomed, Inc. | Prosthesis using biocompatible composite material |
US5258000A (en) * | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
US5843021A (en) * | 1994-05-09 | 1998-12-01 | Somnus Medical Technologies, Inc. | Cell necrosis apparatus |
US5988171A (en) * | 1997-06-26 | 1999-11-23 | Influence Medical Technologies, Ltd. | Methods and devices for the treatment of airway obstruction, sleep apnea and snoring |
US6161541A (en) * | 1998-06-09 | 2000-12-19 | Influent Ltd. | Hyoid expansion and suspension procedure |
US7078378B1 (en) * | 1998-06-18 | 2006-07-18 | Avastra Ltd. | Method of tissue repair II |
US20060029591A1 (en) * | 1998-10-06 | 2006-02-09 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
US6918396B1 (en) * | 1998-12-01 | 2005-07-19 | Purdue Research Foundation | Method for vocal cord reconstruction |
US7048753B2 (en) * | 1999-03-17 | 2006-05-23 | Poly-Med, Inc. | Coated, slow-absorbing textile constructs for sutures and tissue engineering |
US6250307B1 (en) * | 1999-09-17 | 2001-06-26 | Pi Medical, Inc. | Snoring treatment |
US6513530B2 (en) * | 1999-09-17 | 2003-02-04 | Pi Medical, Inc. | Braided palatal implant for snoring treatment |
US6523541B2 (en) * | 1999-09-17 | 2003-02-25 | Pi Medical, Inc. | Delivery system for snoring treatment implant and method |
US6523542B2 (en) * | 1999-09-17 | 2003-02-25 | Pi Medical, Inc. | Snoring treatment implant and method |
US6601584B2 (en) * | 1999-09-17 | 2003-08-05 | Pi Medical, Inc. | Contracting snoring treatment implant |
US6997956B2 (en) * | 1999-10-20 | 2006-02-14 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US6413254B1 (en) * | 2000-01-19 | 2002-07-02 | Medtronic Xomed, Inc. | Method of tongue reduction by thermal ablation using high intensity focused ultrasound |
US7081086B2 (en) * | 2000-03-10 | 2006-07-25 | Paracor Medical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US6431174B1 (en) * | 2000-08-10 | 2002-08-13 | Pi Medical, Inc. | Method and apparatus to treat conditions of the naso-pharyngeal area |
US20020083820A1 (en) * | 2000-10-10 | 2002-07-04 | Greenhalgh E. Skott | Stiffened fabric |
US20040020492A1 (en) * | 2002-05-02 | 2004-02-05 | Dubrul William R. | Upper airway device and method |
US6736823B2 (en) * | 2002-05-10 | 2004-05-18 | C.R. Bard, Inc. | Prosthetic repair fabric |
US20040028676A1 (en) * | 2002-08-06 | 2004-02-12 | Klein Dean A. | Swallowing system tissue modifier |
US20040139975A1 (en) * | 2002-09-06 | 2004-07-22 | Apneon, Inc. | Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit |
US6955172B2 (en) * | 2002-09-06 | 2005-10-18 | Apneon, Inc. | Systems and methods for moving and/or restraining the tongue in the oral cavity |
US20040045556A1 (en) * | 2002-09-06 | 2004-03-11 | Swan Medical | Systems and methods for moving and/or restraining tissue in the upper respiratory system |
US7073505B2 (en) * | 2002-09-06 | 2006-07-11 | Apneon, Inc. | Systems and methods for moving and/or restraining tissue in the oral cavity |
US20040149290A1 (en) * | 2002-09-06 | 2004-08-05 | Apneon, Inc. | Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit |
US20050004417A1 (en) * | 2002-09-06 | 2005-01-06 | Apneon, Inc. | Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit |
US20050199248A1 (en) * | 2002-12-30 | 2005-09-15 | Quiescence Medical, Inc. | Apparatus and methods for treating sleep apnea |
US20060157055A1 (en) * | 2002-12-30 | 2006-07-20 | Pflueger D R | Apparatus and methods for treating sleep apnea |
US20040134491A1 (en) * | 2002-12-30 | 2004-07-15 | Quiescence Medical | Apparatus and methods for treating sleep apnea |
US20060153816A1 (en) * | 2003-06-27 | 2006-07-13 | Laura Brown | Soft tissue repair and regeneration using postpartum-derived cells and cell products |
US20050154412A1 (en) * | 2003-09-19 | 2005-07-14 | Restore Medical, Inc. | Airway implant and delivery tool |
US20050092332A1 (en) * | 2003-10-31 | 2005-05-05 | Restore Medical, Inc. | Airway implant |
US20050092334A1 (en) * | 2003-10-31 | 2005-05-05 | Restore Medical, Inc. | Airway implant |
US20050142163A1 (en) * | 2003-11-10 | 2005-06-30 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US20050126563A1 (en) * | 2003-12-15 | 2005-06-16 | Van Der Burg Erik J. | System and method for hyoidplasty |
US20050281883A1 (en) * | 2004-04-28 | 2005-12-22 | Daniloff George Y | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
US20050267321A1 (en) * | 2004-06-01 | 2005-12-01 | Shadduck John H | Elastomeric magnetic nanocomposite biomedical devices |
US20060070626A1 (en) * | 2004-10-04 | 2006-04-06 | Andrew Frazier | System and method for airway manipulation |
US20060235264A1 (en) * | 2005-04-15 | 2006-10-19 | Restore Medical, Inc. | Implant for tongue |
US20060235380A1 (en) * | 2005-04-15 | 2006-10-19 | Restore Medical, Inc. | Tissue incision tool |
Cited By (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080261886A1 (en) * | 2001-07-16 | 2008-10-23 | Novo Nordisk Healthcare A/G | Single-Dose Administration of Factor VIIa |
US8747296B2 (en) | 2008-01-03 | 2014-06-10 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US20090177027A1 (en) * | 2008-01-03 | 2009-07-09 | Gillis Edward M | Partially erodable systems for treatment of obstructive sleep apnea |
US8523760B2 (en) | 2008-01-03 | 2013-09-03 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US8167787B2 (en) | 2008-01-03 | 2012-05-01 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US8991398B2 (en) | 2008-05-12 | 2015-03-31 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US8707960B2 (en) | 2008-05-12 | 2014-04-29 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US8327854B2 (en) | 2008-05-12 | 2012-12-11 | Revent Medical, Inc. | Partially erodable systems for treatment of obstructive sleep apnea |
US20100024830A1 (en) * | 2008-07-30 | 2010-02-04 | Ethicon, Inc. | Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea |
US8678008B2 (en) | 2008-07-30 | 2014-03-25 | Ethicon, Inc | Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea |
US20100030011A1 (en) * | 2008-07-31 | 2010-02-04 | Ethicon, Inc. | Magnetic implants for treating obstructive sleep apnea and methods therefor |
US8556797B2 (en) | 2008-07-31 | 2013-10-15 | Ethicon, Inc. | Magnetic implants for treating obstructive sleep apnea and methods therefor |
US8413661B2 (en) | 2008-08-14 | 2013-04-09 | Ethicon, Inc. | Methods and devices for treatment of obstructive sleep apnea |
US20100037901A1 (en) * | 2008-08-14 | 2010-02-18 | Rousseau Robert A | Methods and devices for treatment of obstructive sleep apnea |
US9144511B2 (en) | 2008-08-14 | 2015-09-29 | Ethicon, Inc. | Methods and devices for treatment of obstructive sleep apnea |
US8561616B2 (en) | 2008-10-24 | 2013-10-22 | Ethicon, Inc. | Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea |
US20100108077A1 (en) * | 2008-10-30 | 2010-05-06 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8561617B2 (en) | 2008-10-30 | 2013-10-22 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8915252B2 (en) | 2008-12-01 | 2014-12-23 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US20100132719A1 (en) * | 2008-12-01 | 2010-06-03 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8783258B2 (en) | 2008-12-01 | 2014-07-22 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US8800567B2 (en) | 2008-12-01 | 2014-08-12 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US20100294284A1 (en) * | 2008-12-09 | 2010-11-25 | H-Medical | Apparatus, systems, and methods for constraining and/or supporting tissue structures along an airway |
US8695607B2 (en) | 2008-12-09 | 2014-04-15 | Sileomed, Inc. | Apparatus, systems, and methods for constraining and/or supporting tissue structures along an airway |
US20100163056A1 (en) * | 2008-12-30 | 2010-07-01 | Medartis Ag | Implant |
US10441456B2 (en) | 2008-12-30 | 2019-10-15 | Medartis Ag | Implant |
US8813754B2 (en) | 2009-02-17 | 2014-08-26 | Ethicon, Inc. | Magnetic implants and methods for treating an oropharyngeal condition |
US8307831B2 (en) | 2009-03-16 | 2012-11-13 | Ethicon, Inc. | Implant systems and methods for treating obstructive sleep apnea |
US9950166B2 (en) | 2009-10-20 | 2018-04-24 | Nyxoah SA | Acred implant unit for modulation of nerves |
US10716940B2 (en) | 2009-10-20 | 2020-07-21 | Nyxoah SA | Implant unit for modulation of small diameter nerves |
US9943686B2 (en) | 2009-10-20 | 2018-04-17 | Nyxoah SA | Method and device for treating sleep apnea based on tongue movement |
US9849289B2 (en) | 2009-10-20 | 2017-12-26 | Nyxoah SA | Device and method for snoring detection and control |
US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
US11857791B2 (en) | 2009-10-20 | 2024-01-02 | Nyxoah SA | Arced implant unit for modulation of nerves |
US10898717B2 (en) | 2009-10-20 | 2021-01-26 | Nyxoah SA | Device and method for snoring detection and control |
US11273307B2 (en) | 2009-10-20 | 2022-03-15 | Nyxoah SA | Method and device for treating sleep apnea |
US9326886B2 (en) | 2009-10-29 | 2016-05-03 | Ethicon, Inc. | Fluid filled implants for treating obstructive sleep apnea |
WO2011059629A1 (en) * | 2009-10-29 | 2011-05-19 | Ethicon, Inc. | Tongue suspension system with hyoid-extender for treating obstructive sleep apnea |
JP2013509242A (en) * | 2009-10-29 | 2013-03-14 | エシコン・インコーポレイテッド | Tongue suspension system using hyoid extender to treat obstructive sleep apnea |
US9877862B2 (en) | 2009-10-29 | 2018-01-30 | Ethicon, Inc. | Tongue suspension system with hyoid-extender for treating obstructive sleep apnea |
US9974683B2 (en) | 2009-10-30 | 2018-05-22 | Ethicon, Inc. | Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea |
US20110100378A1 (en) * | 2009-10-30 | 2011-05-05 | Ethicon, Inc. | Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea |
US8632488B2 (en) | 2009-12-15 | 2014-01-21 | Ethicon, Inc. | Fluid filled implants for treating medical conditions |
US8776799B2 (en) | 2010-03-19 | 2014-07-15 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US20140261451A1 (en) * | 2010-03-19 | 2014-09-18 | Edward M. Gillis | Systems and methods for treatment of sleep apnea |
US20110226262A1 (en) * | 2010-03-19 | 2011-09-22 | Gillis Edward M | Systems and methods for treatment of sleep apnea |
US9381109B2 (en) * | 2010-03-19 | 2016-07-05 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US8733363B2 (en) | 2010-03-19 | 2014-05-27 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US20110226263A1 (en) * | 2010-03-19 | 2011-09-22 | Gillis Edward M | Systems and methods for treatment of sleep apnea |
US9510922B2 (en) | 2010-05-21 | 2016-12-06 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US9707122B2 (en) | 2010-07-26 | 2017-07-18 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US9592046B2 (en) | 2011-09-28 | 2017-03-14 | Ethicon, Inc. | Modular tissue securement systems |
US8905033B2 (en) | 2011-09-28 | 2014-12-09 | Ethicon, Inc. | Modular tissue securement systems |
US9161855B2 (en) | 2011-10-24 | 2015-10-20 | Ethicon, Inc. | Tissue supporting device and method |
US8973582B2 (en) | 2011-11-30 | 2015-03-10 | Ethicon, Inc. | Tongue suspension device and method |
US10470760B2 (en) | 2011-12-08 | 2019-11-12 | Ethicon, Inc. | Modified tissue securement fibers |
US9173766B2 (en) | 2012-06-01 | 2015-11-03 | Ethicon, Inc. | Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients |
US9439801B2 (en) | 2012-06-29 | 2016-09-13 | Revent Medical, Inc. | Systems and methods for treatment of sleep apnea |
US20140007885A1 (en) * | 2012-07-06 | 2014-01-09 | Edward M. Gillis | Systems and methods for treatment of sleep apnea |
US9855032B2 (en) | 2012-07-26 | 2018-01-02 | Nyxoah SA | Transcutaneous power conveyance device |
US10716560B2 (en) | 2012-07-26 | 2020-07-21 | Nyxoah SA | Implant unit delivery tool |
US10814137B2 (en) | 2012-07-26 | 2020-10-27 | Nyxoah SA | Transcutaneous power conveyance device |
US10918376B2 (en) | 2012-07-26 | 2021-02-16 | Nyxoah SA | Therapy protocol activation triggered based on initial coupling |
US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
US11730469B2 (en) | 2012-07-26 | 2023-08-22 | Nyxoah SA | Implant unit delivery tool |
US10314736B2 (en) | 2012-10-16 | 2019-06-11 | Cook Medical Technologies Llc | Method and apparatus for treating obstructive sleep apnea (OSA) |
US10512782B2 (en) | 2013-06-17 | 2019-12-24 | Nyxoah SA | Remote monitoring and updating of a medical device control unit |
US11298549B2 (en) | 2013-06-17 | 2022-04-12 | Nyxoah SA | Control housing for disposable patch |
US11642534B2 (en) | 2013-06-17 | 2023-05-09 | Nyxoah SA | Programmable external control unit |
US9643022B2 (en) | 2013-06-17 | 2017-05-09 | Nyxoah SA | Flexible control housing for disposable patch |
Also Published As
Publication number | Publication date |
---|---|
US7845357B2 (en) | 2010-12-07 |
US20100059065A1 (en) | 2010-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7845357B2 (en) | Tongue implant for sleep apnea | |
US8381735B2 (en) | Tongue implant | |
US6523542B2 (en) | Snoring treatment implant and method | |
US6513531B2 (en) | Proximal placement of snoring treatment implant | |
KR100869864B1 (en) | Braided palatal implant for snoring treatment | |
US6523541B2 (en) | Delivery system for snoring treatment implant and method | |
US7100613B2 (en) | Braided implant for snoring treatment | |
US6899105B2 (en) | Airway implant cartridge and kit | |
US6601584B2 (en) | Contracting snoring treatment implant | |
US6516806B2 (en) | Compliant snoring treatment implant | |
US6415796B1 (en) | Placement tool for snoring treatment | |
US7237553B2 (en) | Needle with pre-loaded implant for snoring treatment | |
NO318637B1 (en) | Implants and methods of treatment for snoring | |
US20050065615A1 (en) | Airway implant and delivery tool and kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: RESTORE MEDICAL, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BUSCEMI, PAUL J.;KRUEGER, KURT D.;REEL/FRAME:018381/0745 Effective date: 20061002 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |